Chronic tubulointerstitial nephropathy associated with urothelial carcinoma is described in three clinical entities in the renal literature: analgesic nephropathy, Chinese herbs nephropathy (CHN), and Balkan endemic nephropathy (BEN).
Bilateral calcifying renal papillary necrosis associated with interstitial fibrosis and tubular atrophy resulting in pronounced cortical retraction found in patients with long-term abuse of combined analgesics associated with addictive substances is characteristic of analgesic nephropathy ( Table 1 ) . Using computed tomographic scanning without contrast medium as renal imaging technique allows a correct diagnosis for these patients. 1 Th e clinical expression and pathological lesions observed at different stages of CHN and BEN are strikingly similar except for the rate of their progression toward end-stage renal failure. Furthermore, a strikingly higher prevalence rate of women presenting with CHN is observed, whereas BEN is characterized by familial clustering ( Table 1 ) .
In 1991, nephrologists in the area around Brussels, Belgium, noted an increasing number of relatively young women who presented with different degrees of renal failure. All had attended the same private ' slimming ' clinic and had ingested a mixture of several drugs and powdered extracts of Chinese herbs containing Aristolochia fangchi . 2 Th e exposure to the inadvertently added Aristolochia plant containing aristolochic acid (AA) turned out to be the most likely cause of the renal injury and later development of urothelial-cell atypia and carcinoma.
Very soon aft er the publication of the index cases, patients presenting with a similar clinicopathological entity were reported in several countries around the world.
A couple of years later, reports from Taiwan and mainland China confi rmed the high prevalence of chronic tubulointerstitial renal disease in end-stage renal failure patients associated with the use of herbal medicines containing AA, 3 partly explaining the very high incidence of end-stage renal disease in Taiwan, based on an excellent registration system covering the whole country.
Several experimental models in rabbits, rats, and mice were able to reproduce the nephrotoxic and carcinogenic eff ects of AA observed in humans. 4, 5 Furthermore, the carcinogenic and mutagenic eff ects associated with the binding of metabolites of ingested AA to DNA have been extensively described in vitro and in vivo , resulting in the classifi cation of AA as a genotoxic carcinogen. 6 Cosyns et al. 7 documented pathological evidence of urothelial malignancy and overexpression of p53, a tumor suppressor gene known to be mutated in several types of malignancies, in the removed kidneys of almost all CHN patients. A high prevalence of urothelial malignancy was confi rmed a year later in the series of Nortier et al. 8 Th e latter study also demonstrated that the risk of urothelial carcinoma was related to the cumulative intake of A. fangchi , and that all patients exposed to AA had AA-related DNA adducts in specimens of renal tissue.
Already in 2001, there was a call to change the term ' Chinese herbs nephro pathy ' to ' aristolochic acid nephropathy. ' 9 Balkan endemic nephropathy (BEN) is a tubulointerstitial nephropathy and was described already some 50 years ago. Th e renal disease tends to occur in people older than 18 years and in members of the same household, typically living in farming villages located near tributaries of the Danube in the Balkan area and Romania. BEN has the same renal localization and association with upper urinary tract malignancy that are observed in patients with CHN. 10 Over the years an impressive number of potential etiological agents (factors) have been proposed, such as environmental factors, mycotoxins (in particular, ochratoxin A), heavy metals, viruses, and tracemetal defi ciencies. However, none of these studies collected or delivered convincing toxico-epidemiological data.
The ochratoxin A (OTA) hypothesis was based on the fact that residents in endemic regions are exposed to relatively high concentrations of OTA. 11 However, similar high exposure occurs throughout the world in farming communities that are largely free of chronic kidney disease and urothelial malignancy. Furthermore, chronic nephrotoxicity associated with dietary exposure to OTA has never been observed in humans. 12 Already in 1969 Ivi ć 13 proposed that ingestion of fl our contaminated with seeds from Aristolochia clematitis may be the cause of BEN. He noted that seeds from these plants, which grew abundantly in local wheat fi elds, comingled with wheat grain during the harvesting process. He administered Aristolochia seeds to animals that developed renal damage, and speculated that human exposure to a toxic component of Aristolochia seeds could occur through ingestion of bread prepared with fl our derived from contaminated grain. However, his fi eld surveys and data failed to provide convincing evidence, and his astute observations were neglected for many decades.
Th e fi nding by Grollman and colleagues of AA-derived DNA adducts in renal cortical and urothelial tumor tissue of patients with documented BEN, associated with the dominance of the A:T ; T:A transversions in the p53 tumor suppressor gene mutational spectrum, was a breakthrough in the identifi cation of AA as an etiological agent of the upper tract malignancy observed in BEN. 14 Th e observed mutational spectra in urothelial cancers among BEN patients resemble the mutational ' signature ' observed in cultured cells and rodents treated with AA. 15 Jelakovi ć et al. 16 (this issue) now extend their previous observations, 14 presenting molecular epidemiological evidence relating urothelial-cell carcinoma of the upper urinary tract to dietary exposure to AA through the contamination of fl our prepared from locally grown wheat grain in the endemic cohort. Aristolactam-DNA adducts were present in 70 % of the endemic cohort ( n = 67) and in 94 % of subjects with A:T ; T:A mutations in TP53 . In contrast, neither aristolactam-DNA adducts nor A:T ; T:A mutations were detected in tumors of upper urinary tract carcinoma patients ( n = 10) residing in non-endemic regions (regions not exposed to AA).
Jelakovi ć et al. 16 propose a molecular epidemiological approach using deoxyadenosine-aristolactam adducts and TP53 mutational spectra as biomarkers of exposure to and carcinogenic eff ects of AA in the evaluation of the disease in countries where Aristolochia species have been used for medicinal purposes.
In summary, the etiology of CHN and BEN is exposure to Aristolochia containing AA, a toxic component of all Aristolochia species. Th e slower progression toward end-stage renal failure of patients with BEN has to do with lower doses of AA ingested during the consumption of contaminated bread as compared with the high dose of AA found in the herbal mixtures used by patients in the ' slimming ' clinic. Th e higher prevalence of women in the CHN cohorts can be attributed to the fact that young women are more likely to attend such clinics.
Recently, the National Toxicology Program reported that AA was carcinogenic to humans. Th e report suggested that ' sufficient ' scientific evidence was available to conclude that exposure to AA causes urothelial cancer in humans through formation of DNA adducts (specifically, through binding of the reactive metabolite with adenine) and the resulting transversion mutations in oncogenes. 17 The exact mechanism, however, by which exposure to AA results in chronic renal damage remains uncertain.
In a recent study in mice, chronic administration of AA resulted in progressive renal damage. AA was able to activate Smad signaling to mediate epithelial -mesenchymal transition and renal fi brosis via both transforming growth factor--dependent and JNK / MAP kinase-dependent mechanisms. Th e blockade of JNK and specifi c knock-down of Smad3, but not Smad2, were able to attenuate AA-stimulated collagen matrix expression and epithelial -mesenchymal transition. 18 Lebeau et al. 19 showed the involvement of AA in the early proximal tubular dysfunction, such as low-molecular weight proteinuria, found in CHN. Th ey proposed a causal relationship between DNA adduct formation, decreased megalin expression, and inhibition of receptormediated endocytosis of low-molecular weight proteinuria.
In acute aristolochic acid nephropathy in mice, it was found that the AA adducts formed with DNA may lead to tubular epithelial cell apoptosis via p53-mediated signaling. 20 AA induced dephosphorylation of STAT3 and subsequent activation of p53 and tubular epithelial cell apoptosis. In contrast, overexpression of STAT3, p53 inhibition, or p53 knock-down with small interfering RNA attenuated AAinduced tubular epithelial cell apoptosis. Th is supports the hypothesis that p53 promotes renal injury in acute aristolochic acid nephropathy. Th ese results have to be interpreted with caution with regard to humans, in view of the slowly progressive character of the disease in patients. On the other hand, experiments conducted on tissue from patients with BEN indicate that p53 is also activated. Some important conclusions can be inferred from the CHN and BEN stories. For more than 2500 years, the Aristolochia (birthwort) species were among the most extensively described medicinal plants in the Chinese Ayuverdic, Egyptian, Greek ( Figure 1 ) , Coptic, and European literature because of their association with a multitude of pharmacological activities. Remarkably, it was not until the end of the eighteenth century that the fi rst observations of nephrotoxicity related to the use of Aristolochia appeared in the literature. 21 Recently this magic plant turned out to contain a powerful nephrotoxic substance with an ability to induce urothelial cancer.
Aristolochic acid nephropathy remains an underdiagnosed renal illness because of its lack of identifi cation in certain parts of the world. It remains an international public-health problem that can be resolved only through implementation of measures to halt the risk of exposure to this toxic herb.
Th e renal community has to be made aware of the proposed concept that ' CHN ' and ' BEN ' are limitative misnomers. Excellent toxico-epidemiological research, the use of sophisticated biochemical methodologies, and exchange of information in the context of the globalization of nephrology have proven that both clinical entities have a common etiology, that is, AA, justifying the use of ' aristolochic acid nephropathy ' to cover two clinical expressions (CHN and BEN) of that disease.
Aristolochic acid nephropathy is an underdiagnosed and underestimated chronic renal disease associated with a very high risk of developing upper urinary tract urothelial carcinoma, worthwhile to trace in any patient with an unexplained unclassifiable progressive decline in renal function.
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